15,603 reports of this reaction
3.6% of all DULOXETINE HYDROCHLORIDE reports
#2 most reported adverse reaction
FATIGUE is the #2 most commonly reported adverse reaction for DULOXETINE HYDROCHLORIDE, manufactured by Eli Lilly and Company. There are 15,603 FDA adverse event reports linking DULOXETINE HYDROCHLORIDE to FATIGUE. This represents approximately 3.6% of all 434,529 adverse event reports for this drug.
Patients taking DULOXETINE HYDROCHLORIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among DULOXETINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for DULOXETINE HYDROCHLORIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 15,603 FDA reports for DULOXETINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.6% of all adverse event reports for DULOXETINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience fatigue while taking DULOXETINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.